GCAN Market Cap

GCAN has a market cap or net worth of $482.78 thousand as of April 25, 2024. Its market cap has decreased by -5.86% in one year.

Market Cap

482.78K

Enterprise Value

827.83K

1-Year Change

-5.86%

Ranking

n/a

Market Cap Chart

Since April 26, 2019, GCAN's market cap has decreased from $4.13M to $482.78K, a decrease of -88.30%. That is a compound annual growth rate of -34.88%.

Market Cap History

Date	Market Cap	% Change
Apr 25, 2024	553.75K	7.69%
Apr 24, 2024	514.19K	-7.14%
Apr 23, 2024	553.75K	27.27%
Apr 22, 2024	435.09K	-
Apr 19, 2024	435.09K	10.00%
Apr 18, 2024	395.53K	-16.67%
Apr 16, 2024	474.64K	-
Apr 15, 2024	474.64K	-
Apr 12, 2024	474.64K	-14.29%
Apr 11, 2024	553.75K	4.48%
Apr 10, 2024	530.01K	1.52%
Apr 9, 2024	522.10K	-5.71%
Apr 8, 2024	553.75K	-
Apr 5, 2024	553.75K	-
Apr 4, 2024	553.75K	9.38%
Apr 3, 2024	506.28K	6.67%
Apr 2, 2024	474.64K	-10.21%
Apr 1, 2024	528.61K	16.67%
Mar 28, 2024	453.09K	-
Mar 27, 2024	453.09K	7.45%
Mar 25, 2024	421.68K	-15.38%
Mar 22, 2024	498.34K	-7.14%
Mar 21, 2024	536.68K	16.67%
Mar 20, 2024	460.01K	-
Mar 19, 2024	460.01K	20.00%

View and export this data all the way back to 2019. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly	708.98B
Novo Nordisk	559.94B
UnitedHealth Group	448.23B
Johnson & Johnson	360.41B
Merck & Co.	321.34B
AbbVie	300.20B
AstraZeneca	219.62B
Thermo Fisher	219.33B

Market Cap Rankings